| Heartland Home Health Care & Hospice 905-907 West State Street, Fremont, OH, 43420 | |
| (419) 355-9209 |
News Archive
Medtronic Inc. announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity Renal Denervation System for treatment-resistant hypertension.
Researchers at the SUNY Upstate Medical University have found that a key cellular enzyme, c-Abl, could be an effective drug target in cancer cells for urologic cancers, such as prostate and kidney.
The return of daylight saving time and losing an hour of sleep causes most to cringe at the thought. According to Aparajitha Verma, M.D., medical director of the Sleep Disorders Center at the Methodist Neurological Institute in Houston, "springing forward" affects the sleep patterns of more than 70 million Americans. She offers some tips about how to practice good sleep hygiene before March 11 rolls around.
The Cardiovascular Research Foundation (CRF) has announced the late breaking trials and first report investigations that will be presented at next month's Transcatheter Cardiovascular Therapeutics (TCT) 2013 scientific symposium.
Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins.
› Verified 4 days ago
| Name | Heartland Home Health Care & Hospice |
|---|---|
| Location | 905-907 West State Street, Fremont, Ohio |
| Hospice ID | 361595 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| Accreditation Provider | Accreditation Commission for Health Care (ACHC) |
| SSA county code | 730 |
News Archive
Medtronic Inc. announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity Renal Denervation System for treatment-resistant hypertension.
Researchers at the SUNY Upstate Medical University have found that a key cellular enzyme, c-Abl, could be an effective drug target in cancer cells for urologic cancers, such as prostate and kidney.
The return of daylight saving time and losing an hour of sleep causes most to cringe at the thought. According to Aparajitha Verma, M.D., medical director of the Sleep Disorders Center at the Methodist Neurological Institute in Houston, "springing forward" affects the sleep patterns of more than 70 million Americans. She offers some tips about how to practice good sleep hygiene before March 11 rolls around.
The Cardiovascular Research Foundation (CRF) has announced the late breaking trials and first report investigations that will be presented at next month's Transcatheter Cardiovascular Therapeutics (TCT) 2013 scientific symposium.
Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins.
› Verified 4 days ago
| NPI Number | 1306890439 |
| Organization Name | In Home Health Llc |
| Address | 907 W State St Fremont, Ohio, 43420 |
| Phone Number | (419)355-9209 |
News Archive
Medtronic Inc. announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity Renal Denervation System for treatment-resistant hypertension.
Researchers at the SUNY Upstate Medical University have found that a key cellular enzyme, c-Abl, could be an effective drug target in cancer cells for urologic cancers, such as prostate and kidney.
The return of daylight saving time and losing an hour of sleep causes most to cringe at the thought. According to Aparajitha Verma, M.D., medical director of the Sleep Disorders Center at the Methodist Neurological Institute in Houston, "springing forward" affects the sleep patterns of more than 70 million Americans. She offers some tips about how to practice good sleep hygiene before March 11 rolls around.
The Cardiovascular Research Foundation (CRF) has announced the late breaking trials and first report investigations that will be presented at next month's Transcatheter Cardiovascular Therapeutics (TCT) 2013 scientific symposium.
Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins.
› Verified 4 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.6 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 96.5 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 96.9 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 79.7 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.2 | 97.3 |
| Patients who got timely treatment for shortness of breath | 96.2 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 92.3 | 93.3 |
News Archive
Medtronic Inc. announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity Renal Denervation System for treatment-resistant hypertension.
Researchers at the SUNY Upstate Medical University have found that a key cellular enzyme, c-Abl, could be an effective drug target in cancer cells for urologic cancers, such as prostate and kidney.
The return of daylight saving time and losing an hour of sleep causes most to cringe at the thought. According to Aparajitha Verma, M.D., medical director of the Sleep Disorders Center at the Methodist Neurological Institute in Houston, "springing forward" affects the sleep patterns of more than 70 million Americans. She offers some tips about how to practice good sleep hygiene before March 11 rolls around.
The Cardiovascular Research Foundation (CRF) has announced the late breaking trials and first report investigations that will be presented at next month's Transcatheter Cardiovascular Therapeutics (TCT) 2013 scientific symposium.
Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins.
› Verified 4 days ago
| Home Health Aides | 13 |
| Counselors | 1 |
| Licensed Practical or Vocational Nurses | 0.5 |
| Medical Social Workers | 3 |
| Registered Nurses | 10 |
| Other Personnel | 8 |
| Total Employees | 35.5 |
|---|
News Archive
Medtronic Inc. announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity Renal Denervation System for treatment-resistant hypertension.
Researchers at the SUNY Upstate Medical University have found that a key cellular enzyme, c-Abl, could be an effective drug target in cancer cells for urologic cancers, such as prostate and kidney.
The return of daylight saving time and losing an hour of sleep causes most to cringe at the thought. According to Aparajitha Verma, M.D., medical director of the Sleep Disorders Center at the Methodist Neurological Institute in Houston, "springing forward" affects the sleep patterns of more than 70 million Americans. She offers some tips about how to practice good sleep hygiene before March 11 rolls around.
The Cardiovascular Research Foundation (CRF) has announced the late breaking trials and first report investigations that will be presented at next month's Transcatheter Cardiovascular Therapeutics (TCT) 2013 scientific symposium.
Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins.
› Verified 4 days ago
| Heartland Home Health Care & Hospice Location: 905-907 West State Street, Fremont, Ohio, 43420 Phone: (419) 355-9209 |